China’s New Tuberculosis Vaccine Enters Clinical Trials with Promising Results
Chinese researchers launch clinical trials for a groundbreaking mRNA tuberculosis vaccine, promising 20x higher efficacy than traditional options in early tests.
News & Insights Across Asia
Chinese researchers launch clinical trials for a groundbreaking mRNA tuberculosis vaccine, promising 20x higher efficacy than traditional options in early tests.
China’s semi-invasive brain-machine interface enables speech restoration and device control for paralyzed patients, advancing neurotechnology applications.
Leading hepatologist Dr. Xia Qiang discusses how living donor liver transplants are revolutionizing pediatric care in China, offering hope for children with severe liver disease.
Chinese scientists unveil AI tool predicting liver cancer recurrence with 82% accuracy, offering new hope for global oncology care.
China debuts its first fully foreign-owned general hospital in Tianjin, signaling broader healthcare reforms and new opportunities for cross-border collaboration.
Brain-computer interface technology revolutionizes healthcare, tech, and human potential across Asia. Discover how minds are controlling machines today.
China’s healthcare system has transformed since the 1980s, achieving near-universal insurance coverage and world-class medical infrastructure through public-private collaboration and international partnerships.
Chinese scientist Wang Yongjun wins the prestigious Feinberg Award for his groundbreaking contributions to stroke research and treatment.